China’s SDIC Leads $260M Series D Round In Innovent Biologics

Login to View

A fund managed by Chinese state-owned investment entity State Development & Investment Corporation (SDIC) has led a US$260 million series D funding round in Chinese biopharmaceutical company Innovent Biologics, according to Chinese media reports.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now


Already have an account or paid subscription? Log in


RELATED NEWS